Acute Ischemic Stroke (AIS) research hub
3 indexed studies · 3 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
BRIGHT - A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in Subjects with Acute Ischemic Stroke (AIS)
This study, called BRIGHT, is testing a new medicine called LT3001 for people who have recently had a stroke. It's in an early stage (Phase 2), focusing on whether the medicine is safe and if it helps people recover. Some people will get the real medicine, others a dummy treatment.
Spain · Czechia · Germany - recruitingNA
One-Stop manaGemEnT For A Swift Initiation of Endovascular Therapy
This study looks at a faster way to treat stroke caused by a blood clot. It compares a 'One-Stop' approach, where scans and treatment happen in one room, to the usual way. The goal is to help more people recover better and quicker after a stroke.
Germany · Switzerland - recruiting
Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).
This study looks at how well a medical device, the Penumbra System, works and how safe it is for people who have had a type of stroke called an acute ischemic stroke. We want to understand its real-world benefits for patients.
Australia · France · Germany